Tag: RSV
-
There’s a Shortage of RSV Treatments. Here’s What to Know
[ad_1] A recently approved treatment was supposed to protect babies from RSV, but demand is outpacing the supply of the medication. The U.S. Food and Drug Administration approved nirsevimab, an antibody that sticks to and prevents Respiratory Syncytial Virus from infecting cells, in July. The Centers for Disease Control and Prevention (CDC) then recommended the…
-
RSV Vaccines Aren’t Going to the People Who Most Need them
[ad_1] The world is entering a new era of vaccines. Following the success of COVID-19 mRNA shots, scientists have a far greater capacity to tailor shots to a virus’s structure, putting a host of new vaccines on the horizon. The most recent arrivals are several new immunizations against respiratory syncytial virus, or RSV. These shots…
-
RSV Pfizer vaccine to protect infants wins approval from FDA : Shots
[ad_1] An electron micrograph of Respiratory Syncytial Virus, also known as RSV, which is the leading cause of hospitalizations among infants in the U.S. CDC via AP hide caption toggle caption CDC via AP An electron micrograph of Respiratory Syncytial Virus, also known as RSV, which is the leading cause of hospitalizations among infants in…
-
RSV prevention shot for babies gets OK from CDC : Shots
[ad_1] RSV can be dangerous for infants. A new treatment to prevent the respiratory illness is on track to be available this fall. JGI/Tom Grill/Getty Images/Tetra images RF hide caption toggle caption JGI/Tom Grill/Getty Images/Tetra images RF RSV can be dangerous for infants. A new treatment to prevent the respiratory illness is on track to…
-
The FDA has approved RSV shots for babies : NPR
[ad_1] Starting this fall, babies in the U.S. will be able to get a shot that protects them from a severe respiratory illness caused by RSV. The FDA gave its approval on Monday. STEVE INSKEEP, HOST: This fall, many parents in the United States will be able to get a shot for their babies that…
-
RSV and older adults: what you should know
[ad_1] Supported by a leading pharmaceutical company Respiratory Syncytial Virus, or RSV, is a seasonal respiratory virus that can severely impact older adults. Infection control measures and the arrival of expected vaccines to prevent RSV will make it easier than ever to stay healthy this fall and winter. Here’s what you need to know. Although…
-
CDC advisers vote to recommend first RSV vaccines for seniors
[ad_1] The first vaccines to guard against the respiratory illness RSV could soon be available for older adults, ages 60 and over, after a panel of advisers to the Centers for Disease Control and Prevention voted in support of them Wednesday. Their vote, during the first of a three-day meeting of the CDC’s Advisory Committee…
-
RSV antibody drug gets backing from FDA advisors, paving the way for approval : Shots
[ad_1] RSV is a seasonal virus that lands tens of hundreds of younger kids within the hospital yearly. On Thursday, advisors to the FDA voted in favor of approving a long-acting antibody that protects infants from RSV. Christoph Soeder/Image Alliance by way of Getty Photographs disguise caption toggle caption Christoph Soeder/Image Alliance by way of…
-
Pfizer’s Maternal RSV Vaccine First to Win FDA Panel Support
[ad_1] Pfizer Inc.’s vaccine to guard newborns from RSV obtained backing from U.S. regulatory advisers to be used in pregnant moms to guard their newborns, handing the drugmaker a win within the race to dominate immunization towards the virus. All 14 members of the committee that advises the Meals and Drug Administration really useful the…
-
Why It Took So Long to Get an RSV Vaccine
[ad_1] Respiratory syncytial virus (RSV) can dangerously compromise respiration, particularly for infants and the aged. However there was no vaccine to forestall it—till at present. On Could 3, the U.S. Meals and Drug Administration (FDA) accredited the primary vaccine towards RSV, from GlaxoSmithKline (GSK), to forestall respiratory illness in individuals ages 60 and older. The…